Recruiting

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography results, women will be placed into two cohorts using their BI-RADS category. Once mammogram results are available, patients will be randomized 1:1 to either usual care or usual care with chatbot. This study will randomly…

ClinicalTrials.gov IDNCT07029490
PhaseNA
Enrollment2700
SponsorUniversity of Utah
Age18 Years and older
SexFEMALE
I'm interested View official listing

Conditions studied

Breast Cancer

About this study

This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography results, women will be placed into two cohorts using their BI-RADS category. Once mammogram results are available, patients will be randomized 1:1 to either usual care or usual care with chatbot. This study will randomly invite participants from four groups for focus group discussions (FGDs) based on their mammogram results and adherence to screening recommendations

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Adult (equal to or above 18 years old) * English or Spanish speaking * Visit a mammography program for routine screening. Exclusion Criteria: * Patients who are currently in treatment for breast cancer * Patients who are not of 18 years of age. * Patients who don't speak English or Spanish * Men * Cognitive limitations that impede informed consent

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-19.